ARTICLE | Clinical News
AOD9604: Phase IIb completed enrollment
June 7, 2004 7:00 AM UTC
MBP completed enrollment in a double-blind Phase IIb trial in 300 obese but otherwise healthy patients. The company said at least 1/3 of the patients have completed treatment. The 12-week trial's prim...